[1] Yao YL, Yang WM, Seto E. Regulation of Transcription Factor YY1 by Acetylation and Deacetylation[J].Mol Cell Biol,2001, 21(17):5979-5991. [2] Gordon S, Akopyan G, Garban H,et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology[J].Oncogene,2006, 25(8):1125. [3] Vega MI,Huerta-YS,Jazirehi AR,et al.Rituximab(chimeric anti-CD20) sensitizes B-NHL cell lines to Fasinduced apoptosis[J].Oncogene,2005,24(55):8114-8127. [4] Taguchi S,Kawachi Y,Ishitsuka Y,et al.Overexpression of the transcription fact or YinYang1 suppresses differentiation of HaCaT celsinthredimensional cell culture[J].Invest Dermatol,2011,131 (1):37-45. [5] Huber MA, Azoitei N, Baumann B, et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression[J].J Clin Invest, 2004, 114(4):569-581. [6] Yuan P,He XH,Rong YF,et al. KRAS/NF-{kappa}B/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis[J].Cancer Res,2017,77(1):100-111. [7] Bonavida B, Baritaki S. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN circuitry [J].Crit Rev Oncog,2011,16(3-4):211-226. [8] BONAVIDA B,GARBAN H. Nitric oxidemediated sensitization of resistant tumor cells to apoptosis by chemoimmunotherapeutics[J].Redox Biol,2015,6:486-494. [9] Vega MI, Jazirehi AR, Huerta YS,et al. Rituximab induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin’s lymphoma cell line via inhibition of NF-kappaB activity:role of YY1 and Bcl-xL in Fas resistance and chemoresistance,respectively[J].J Immunol,2005, 175(4):2174-2183. [10] Huertayepez S, Vega M, Escotochavez S E, et al. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1[J].Nitric Oxide,2009, 20(1):39-52. [11] 马彦凝. YY1转录因子对乳腺癌细胞自噬过程的表观遗传学调控作用及其机制研究[D].浙江大学, 2016. [12] Zaravinos A, Spandidos DA. Yin yang 1 expression in human tumors[J].Cell Cycle,2010, 9(3):512-522. [13] 程维刚, 刘九洲, 李蕾蕾,等. Yin Yang1在分化甲状腺癌中的表达[J].中华实验外科杂志, 2015, 32(9):2133-2136. [14] 葛欣, 谷庆, 唐益庭,等. 转录因子Yin Yang1(YY1)在食管癌中的表达及其对食管癌细胞功能的影响[J].南京医科大学学报(自然科学版), 2014(7):930-936. [15] Yokoyama NN,Pate KT,Sprowl S,et al. A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer[J].Nucleic Acids Res,2010, 38(19):6375-6388. [16] Zhang JJ,Zhu Y,Xie KL,et al. Yin Yang- 1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism[J].Mol Cancer,2014, 13:130. [17] 王玉, 刘奔, 曲金力,等. YY1基因在肺癌组织中的表达及其对肺癌细胞功能的影响[J].天津医药, 2016, 44(7):839-842. [18] Wan MM,Huang WW,Kute E,et al. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27[J].Am J Pathol,2012, 180(5):2120-2133. [19] Lee MH, Lahusen T, Wang RH, et al. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation[J].Oncogene,2012, 3(11):116-127. [20] Theriault BL,Basavarajappa HD,Lim H,et al. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer[J].PLoS One,2014, 9 (3):e91540. [21] Xia B,Li H,Yang S,et al. MiR 381 inhibits epithelial ovarian cancer malignancy via YY1 suppression[J].Tumour Biol,2016, 37(7):9157-9167. [22] Li Y,Wang F,Xu J,et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29[J].J Pathol,2011,224(4):484-495. [23] Oei SL, Shi Y. Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair[J].Biochem Biophys Res Commun,2001, 284(2):450-454. [24] Chen Y,Jacamo R,Konopleva M,et al. CXCR4 downregulation of let 7a drives chemoresistance in acute myeloid leukemia[J].J Clin Invest,2013, 123(6):2395-2407.
2019, Vol. 36 
